| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Outline of Final Research Achievements |
Immunoblot analyses showed insulin (10nM) increased the levels of phosphorylation of Akt (pAkt) which had anti-apoptotic effects by 4.5±0.7-fold. In contrast, high glucose (HG; 20mM) levels decreased the expression by 7.8%. Insulin increased tyrosine phosphorylation of insulin substrate (IRS)1 by 2-fold in low glucose (LG; 5.6mM), while HG decreased the expression by 10%. Infection with IRS1 using adenoviral vector (Ad-IRS1) decreased HG-induced podocyte apoptosis by 57%. To assess the role of IRS1 in mediating the podocyte apoptosis, IRS1 expression was reduced with siIRS1. Knockdown of IRS1 in podocytes increased apoptosis by 2.4±0.4-fold. Lastly, DPP-4 inhibitor increased the levels of pAkt by 131±28%. These results suggest that increases in insulin signaling activity in podocytes using Ad-IRS1 or DPP-4i could inhibit HG-induced podocyte apoptosis.
|
